A new study by CSHH postdoctoral fellow Dr. Cassandra Quave and colleagues was published this week in the journal PLoS ONE. The paper reports on the activity of a medicinal plant extract in limiting staphylococcal biofilm formation, and improving therapeutic response to several different antibiotics. Biofilms contribute to the intrinsic antibiotic resistance of staph infections and new therapies are in great demand.Visit this link to access the full paper: “Ellagic acid derivatives from Rubus ulmifolius inhibit Staphylococcus aureus biofilm formation and improve response to antibiotics”.
-
Recent Posts
Our Key Topics
9/11 Affordable Care Act aging agriculture AIDS alternative treatment Alzheimer's disease ancient health animal model antibiotic resistance apps art behavior change botanical medicine cancer cardiology center courses depression diet education Emory events exercise food graduation health health care costs HIV immune system information meditation microbiome microbiota Nutrition obama obesity predictive health research seniors smoking cessation soda technology type 2 diabetes undergraduatesCategories